Runners and riders in the Covid vaccine race

Pfizer, AstraZeneca and Moderna have gained acceptance for their Covid vaccines from the Uk regulator and the jabs are currently remaining rolled out. But what about the other vaccine candidates and how quickly will they arrive to market place?

Our list gives a snapshot of what the vaccine landscape seems like.

The life sciences industry’s reaction to the pandemic has been unprecedented both equally in phrases of the pace at which it has created vaccines and its willingness to collaborate with rivals. That has resulted in 237 potential vaccines, of which 64 are in human clinical trials.

Which is good news as, in the vaccines business there is often no “just one-measurement-fits-all” solution, with various nations necessitating various types of vaccines centered on a array of variables like local climate, land mass and demography. In other words and phrases: there is a lot of place in the market place for additional than just one vaccine.

Covid vaccines permitted by the Uk

Pfizer/BioNtech

Uk acceptance day: December 2, 2020

Doses: 2

Efficacy: 90pc +

Style: mRNA

Doses offered or pre-ordered globally: The total sum is undisclosed, but we know it has 300m on buy from the EU and 200m from the US, which, collectively with the Uk, delivers the total to 540m

Doses procured by the Uk: 40m

Producing capability: Up to 2bn doses this 12 months